RELIEF THERAPEUTICS HOLDING/ CH1251125998 /
| 15/11/2024 16:42:32 | Chg. -1.42 | Volume | Bid- | Ask- | Market Capitalization | Dividend Y. | P/E Ratio |
|---|---|---|---|---|---|---|---|
| 6.02CHF | -19.09% | 491 Turnover: 2,955.82 |
-Bid Size: - | -Ask Size: - | 85.65 mill.CHF | - | - |
Assets
| 2015 IFRS in mill. EUR |
2016 IFRS in mill. EUR |
2017 IFRS in mill. EUR |
2018 IFRS in mill. EUR |
2019 IFRS in mill. EUR |
|||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Property and Equipment | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | ||||||
| Intangible Assets | 20.8000 | 30.8000 | 30.8000 | 35.2000 | 19.6000 | ||||||
| Long-Term Investments | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | ||||||
| Fixed Assets | 20.8000 | 30.8000 | 30.8000 | 35.2000 | 19.6000 | ||||||
| Inventories | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | ||||||
| Accounts Receivable | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | ||||||
| Cash and Cash Equivalents | .3000 | .4000 | .1000 | .4000 | .2000 | ||||||
| Current Assets | 7.1000 | .6000 | .2000 | .4000 | .3000 | ||||||
| Total Assets | 27.9000 | 31.4000 | 31 | 35.6000 | 19.9000 | ||||||
Liabilities
| 2015 IFRS in mill. EUR |
2016 IFRS in mill. EUR |
2017 IFRS in mill. EUR |
2018 IFRS in mill. EUR |
2019 IFRS in mill. EUR |
|||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Accounts Payable | .4000 | .4000 | .5000 | .1000 | .3000 | ||||||
| Long-term debt | 1.9000 | - | - | - | - | ||||||
| Liabilities to Banks | 4.2000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | ||||||
| Provisions | .7000 | 6.5000 | 7.5000 | 7.5000 | 2.7000 | ||||||
| Liabilities | 11.5000 | 9.2000 | 10 | 14.3000 | 4.5000 | ||||||
| Share Capital | 5.4000 | 19.5000 | 20.1000 | 20.9000 | 21.1000 | ||||||
| Total Equity | 16.3000 | 22.2000 | 20.9000 | 21.3000 | 14.3000 | ||||||
| Minority Interests | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | ||||||
| Total liabilities equity | 27.9000 | 31.4000 | 31 | 35.6000 | 19.9000 | ||||||
Income Statement
| 2015 IFRS in mill. EUR |
2016 IFRS in mill. EUR |
2017 IFRS in mill. EUR |
2018 IFRS in mill. EUR |
2019 IFRS in mill. EUR |
|||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenues | .2000 | 0.0000 | 0.0000 | .6000 | 0.0000 | ||||||
| Depreciation (total) | .3000 | 14.5000 | - | - | - | ||||||
| Operating Result | -3.5000 | -16.5000 | -1.7000 | -.5000 | -12.1000 | ||||||
| Interest Income | - | - | - | - | - | ||||||
| Income Before Taxes | -4 | -16.8000 | -1.9000 | -.4000 | -12.2000 | ||||||
| Income Taxes | 0.0000 | 0.0000 | -1 | 0.0000 | 4.7000 | ||||||
| Minority Interests Profit | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | ||||||
| Net Income | -8.5000 | -16.8000 | -2.9000 | -.4000 | -7.5000 | ||||||
Per Share
Cash Flow
| 2015 IFRS in mill. EUR |
2016 IFRS in mill. EUR |
2017 IFRS in mill. EUR |
2018 IFRS in mill. EUR |
2019 IFRS in mill. EUR |
|||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash Flow from Operating Activities | -6.2000 | -2.9000 | -1.2000 | -.6000 | -.7000 | ||||||
| Cash Flow from Investing Activities | 1 | .1000 | 0.0000 | 0.0000 | 0.0000 | ||||||
| Cash Flow from Financing | 2.1000 | 3.1000 | .9000 | .7000 | .6000 | ||||||
| Decrease / Increase in Cash | -3 | .4000 | -.3000 | .1000 | -.1000 | ||||||
| Employees | - | - | - | - | - | ||||||
